Anavex Life Sciences
AVXL
70 hedge funds and large institutions have $36.8M invested in Anavex Life Sciences in 2020 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 25 increasing their positions, 15 reducing their positions, and 8 closing their positions.
75% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 8
67% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 15
4% more funds holding
Funds holding: 67 → 70 (+3)
2% more capital invested
Capital invested by funds: $36.1M → $36.8M (+$783K)
4.87% less ownership
Funds ownership: 24.8% → 19.93% (-4.9%)
88% less call options, than puts
Call options by funds: $243K | Put options by funds: $1.98M
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$1.14M |
| 2 |
BlackRock
New York
|
+$1.11M |
| 3 |
Russell Investments Group
London,
United Kingdom
|
+$841K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$364K |
| 5 |
N
Nuveen
Charlotte,
North Carolina
|
+$354K |
Top Sellers
| 1 |
PWAM
Park West Asset Management
San Francisco,
California
|
-$8.73M |
| 2 |
HP
Hikari Power
Tokyo,
Japan
|
-$1.15M |
| 3 |
Morgan Stanley
New York
|
-$210K |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$206K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$195K |
AVXL Hedge Fund Activity: Q1 2020 in Review
70 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2020, worth a combined $36.8M — up 2.2% from $36.1M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new AVXL positions and 8 closed out — a net gain of 6 holders — while 25 added to existing stakes and 15 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $1.14M. The largest seller was Park West Asset Management, exiting entirely with an estimated $8.73M sold.
- 70 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2020, up from 67 in Q4 2019.
- Funds reported $36.8M of Anavex Life Sciences stock for Q1 2020, up 2.2% quarter-over-quarter.
- 14 funds opened new Anavex Life Sciences positions in Q1 2020 and 8 closed out, a net change of +6 holders.
- The largest Anavex Life Sciences buyer in Q1 2020 was Renaissance Technologies, an estimated $1.14M added.
- The largest Anavex Life Sciences seller in Q1 2020 was Park West Asset Management, an estimated $8.73M sold.
Based on aggregated 13F filings for Q1 2020.